As to what might be the precise upstream inputs and downstream effectors of this novel ErbB2/EGFR-ERK1/2-ROCK pathway in mediating diabetes-induced vascular dysfunction are not clear. This evidence concerns the gene ERBB2 and diabetes mellitus.